Fna bx w/us gdn ea addl
CPT code 10006 covers each additional fine needle aspiration (FNA) biopsy performed with ultrasound guidance during the same session, after the first biopsy. This is an add-on code used when multiple tissue samples are taken from different sites or lesions during one procedure.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always bill 10006 with the primary FNA code (10005, 10004, 10021, 19083, or 19085) - this is an add-on code that cannot be billed alone
Impact: Prevents 100% denial; add-on codes without primary codes are automatically rejected by Medicare and commercial payers
Document each distinct lesion location with specific anatomic landmarks, sizes, and ultrasound characteristics in the procedure note
Impact: Reduces denial rate by 40-60%; medical necessity denials are the most common reason for 10006 rejections
Bill one unit of 10006 for each additional lesion beyond the first - if three lesions are biopsied, bill the primary code once plus two units of 10006
Impact: Each properly documented additional site generates $47.87-$58.22 in revenue; underbilling costs average $100-$200 per multi-lesion procedure
Use appropriate anatomic modifiers (RT/LT) or XS modifier when biopsying multiple sites to prevent NCCI edits and bundling denials
Impact: Increases first-pass claim acceptance rate by 25-35% and reduces accounts receivable days
Verify pathology documentation confirms separate specimens were submitted with distinct labeling for each biopsy site
Impact: Correlating billing with pathology records prevents post-payment audits and recoupment demands averaging $300-$500 per audit
Check payer-specific policies on maximum billable units per session - some payers limit to 3-4 additional sites without prior authorization
Impact: Prevents denials on higher unit claims; obtaining prior auth for extensive staging biopsies protects $200+ in potential revenue
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.